BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 38066909)

  • 1. Acute leukemias and complicated lymphomas: pearls to optimize management when patients stay local.
    Patel-Donnelly D; Gandhi M
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):311-317. PubMed ID: 38066909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
    Falanga A; Rickles FR
    Hematology Am Soc Hematol Educ Program; 2007; ():165-71. PubMed ID: 18024625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Kidney involvement in hematologic malignancies. Diagnostic approach].
    Jourde-Chiche N; Dussol B; Daniel L
    Rev Med Interne; 2010 Oct; 31(10):685-96. PubMed ID: 20483511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Modern approach to diagnosis and therapy in childhood leukemias].
    Hasanbegović E
    Med Arh; 2004; 58(1):59-60. PubMed ID: 15017909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostic value of anti-terminal deoxynucleotidyl transferase antibody (TdT) in hematologic pathology].
    Valmary S; Danjoux M; Delsol G; Brousset P
    Ann Pathol; 2005 Feb; 25(1):25-32. PubMed ID: 15981929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoma and leukemia complicating pregnancy.
    Peleg D; Ben-Ami M
    Obstet Gynecol Clin North Am; 1998 Jun; 25(2):365-83. PubMed ID: 9629577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic Malignancies Discovered on Investigation of Breast Abnormalities.
    Alsadi A; Lin D; Alnajar H; Brickman A; Martyn C; Gattuso P
    South Med J; 2017 Oct; 110(10):614-620. PubMed ID: 28973700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and classification of hematologic malignancies on the basis of genetics.
    Taylor J; Xiao W; Abdel-Wahab O
    Blood; 2017 Jul; 130(4):410-423. PubMed ID: 28600336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone Marrow Immunohistochemistry and Flow Cytometry in the Diagnosis of Malignant Hematologic Diseases With Emphasis on Lymphomas: A Comparative Retrospective Study.
    Landry M; Bienz MN; Sawan B; Temmar R; Beauregard P; Chaunt F; Lavigne J; Knecht H
    Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):508-512. PubMed ID: 31290784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic aspects of lymphoma and leukemias.
    McCoyd M; Gruener G; Foy P
    Handb Clin Neurol; 2014; 120():1027-43. PubMed ID: 24365369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal antibodies for lymphomas and leukemias in 2005].
    Peffault de Latour R; Robin M; Bay JO
    Bull Cancer; 2006 Jan; 93(1):107-18. PubMed ID: 16455513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased risk of hematologic malignancies in primary immunodeficiency disorders: opportunities for immunotherapy.
    Verhoeven D; Stoppelenburg AJ; Meyer-Wentrup F; Boes M
    Clin Immunol; 2018 May; 190():22-31. PubMed ID: 29499421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling data in lymphoma and leukemia: review of the literature and extrapolation of pertinent clinical applications.
    Dunphy CH
    Arch Pathol Lab Med; 2006 Apr; 130(4):483-520. PubMed ID: 16594743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis of hematologic malignancies does not predict intensive care unit mortality.
    Massion PB; Dive AM; Doyen C; Bulpa P; Jamart J; Bosly A; Installé E
    Crit Care Med; 2002 Oct; 30(10):2260-70. PubMed ID: 12394954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combined chemotherapy for hemoblastoses and therapy for acute respiratory failure in intensive care conditions].
    Galstian GM; Kesel'man SA; Gorodetskiĭ VM; Aleksanian MZh; Kulikov SM; Gemdzhian EG; Parovichnikova EN; Savchenko VG; Vorob'ev AI
    Ter Arkh; 2009; 81(12):37-43. PubMed ID: 20481047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hematologic malignancies. Leukemia, lymphoma, and myeloma.
    Freireich EJ; Keating M; Cabanillas F; Barlogie B
    Cancer; 1984 Dec; 54(11 Suppl):2741-50. PubMed ID: 6208991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 013 (CD99) positivity in hematologic proliferations correlates with TdT positivity.
    Robertson PB; Neiman RS; Worapongpaiboon S; John K; Orazi A
    Mod Pathol; 1997 Apr; 10(4):277-82. PubMed ID: 9110287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematologic Malignancies Identified in Patients with Hypereosinophilia and Hypereosinophilic Syndromes.
    Jin JJ; Butterfield JH; Weiler CR
    J Allergy Clin Immunol Pract; 2015; 3(6):920-5. PubMed ID: 26342744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary CNS lymphoma and neurologic complications of hematologic malignancies.
    Nayak L; Pentsova E; Batchelor TT
    Continuum (Minneap Minn); 2015 Apr; 21(2 Neuro-oncology):355-72. PubMed ID: 25837901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocytes for leukemia and lymphoma.
    Bollard CM; Barrett AJ
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):565-9. PubMed ID: 25696912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.